Development and evaluation of berberine-loaded bigel for the treatment of hyperpigmentation on B16F10 melanoma cell line.

Nanomedicine (London, England) Pub Date : 2024-01-01 Epub Date: 2024-07-26 DOI:10.1080/17435889.2024.2370759
Bharti Mangla, Pankaj Kumar, Zuber Ahamad, Shamama Javed, Waquar Ahsan, Geeta Aggarwal
{"title":"Development and evaluation of berberine-loaded bigel for the treatment of hyperpigmentation on B16F10 melanoma cell line.","authors":"Bharti Mangla, Pankaj Kumar, Zuber Ahamad, Shamama Javed, Waquar Ahsan, Geeta Aggarwal","doi":"10.1080/17435889.2024.2370759","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> The aim of this study was to optimize, develop, characterize and evaluate a topical nanobigel (BG) formulation containing Berberine (BRB) that exhibits anti-melanogenic properties.<b>Materials & methods:</b> The Berberine-loaded bigel (BRB@BG) formulation was prepared by homogenously mixing the optimized hydrogel and oleogel. BRB@BG was characterized <i>in vitro</i> and cytotoxicity study was conducted to evaluate its effects on murine skin melanoma B16F10 cell lines.<b>Results:</b> The optimized BRB@BG exhibited uniform texture with nanometric size, desirable spreadability and extrudability, suitable for topical applications. Cytotoxicity studies revealed that BRB@BG had a lower IC<sub>50</sub> value (4.84 μg/ml) on B16F10 cell lines compared with drug alone.<b>Conclusion:</b> In conclusion, the developed BRB@BG formulation showed good potential as safe and effective topical treatment for hyperpigmentation.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11389747/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17435889.2024.2370759","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/26 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: The aim of this study was to optimize, develop, characterize and evaluate a topical nanobigel (BG) formulation containing Berberine (BRB) that exhibits anti-melanogenic properties.Materials & methods: The Berberine-loaded bigel (BRB@BG) formulation was prepared by homogenously mixing the optimized hydrogel and oleogel. BRB@BG was characterized in vitro and cytotoxicity study was conducted to evaluate its effects on murine skin melanoma B16F10 cell lines.Results: The optimized BRB@BG exhibited uniform texture with nanometric size, desirable spreadability and extrudability, suitable for topical applications. Cytotoxicity studies revealed that BRB@BG had a lower IC50 value (4.84 μg/ml) on B16F10 cell lines compared with drug alone.Conclusion: In conclusion, the developed BRB@BG formulation showed good potential as safe and effective topical treatment for hyperpigmentation.

开发和评估用于治疗 B16F10 黑色素瘤细胞系色素沉着的小檗碱负载 bigel。
目的:本研究旨在优化、开发、表征和评估一种含有小檗碱(BRB)、具有抗黑色素生成特性的局部纳米凝胶(BG)配方。材料与方法:将优化的水凝胶和油凝胶均匀混合,制备出小檗碱负载 bigel(BRB@BG)配方。对 BRB@BG 进行了体外表征和细胞毒性研究,以评估其对小鼠皮肤黑色素瘤 B16F10 细胞系的影响。结果显示优化后的 BRB@BG 具有纳米级的均匀质地、理想的铺展性和挤出性,适合局部应用。细胞毒性研究表明,与单独使用药物相比,BRB@BG 对 B16F10 细胞株的 IC50 值(4.84 μg/ml)更低。结论总之,所开发的 BRB@BG 制剂显示出作为安全有效的色素沉着局部治疗药物的良好潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信